Already Registered? Log In Now Not Registered?
Complete this form to enter the webcast. Already Registered?

(* indicates required field)

Complete this form to enter the webcast.
(* indicates required field)



*Denotes required.


Frontiers in Nanotechnologies for Delivery of Small Molecules and Biologics

This event is now available on demand.

Event Overview: 

As more new molecules coming out of discovery are poorly soluble, formulating and bringing them to clinic has become a phenomenal task. Drug manufactures are at the cross roads and looking for innovative technologies and contract manufactures with right expertise and manufacturing capabilities to expedite the development of drugs for commercialization. Ascendia, a specialty CDMO, with the expertise in formulation and drug development and cGMP manufacturing of sterile and non-sterile products, is leading the way and remains at the forefront for brining those difficult molecules across all modalities to innovator's pipelines by using its proprietary technologies, including LipidSol, NanoSol, EmulSol and AmorSol.

This webinar will focus on the challenges with poorly soluble molecules and finding ways to improve the performance and bioavailability of those small molecules and biologics by employing polymeric and lipid nanotechnologies with the relevant case studies.

Key Learning Objectives: 
  • How to tackle poorly soluble molecules across all modalities
  • What to know about polymeric nanoparticles (PNPs) and lipid nanoparticles (LNPs)
  • cGMP manufacturing and capabilities of PNPs/LNPs
Who Should Attend: 
  • Formulation scientists working with poorly soluble small and large molecules
  • Managers, vice presidents and chief scientific officers working with challenging molecules
  • Students and professors interested in innovative approaches for improving the solubility and bioavailability of molecules
Featured Speaker
Shaukat Ali, PhD
Shaukat Ali, PhD
Sr. Director Scientific Affairs and Technical Marketing
Ascendia Pharma


Dr Shaukat Ali joins Ascendia Pharmaceuticals Inc. as senior director of scientific affairs and technical marketing after having worked in the pharma and biotech industry for nearly 30 years. His areas of expertise include lipid chemistry; liposomes; surfactant-based drug delivery systems; SEDDS/SMEDDS; amorphous solid dispersions; oral, parenteral, topical and transdermal drug delivery; and immediate and controlled release formulations. He received his PhD in Organic Chemistry from the City University of New York and received postdoctoral training in Physical Biochemistry of lipids at the University of Minnesota and Cornell University.

Dr Ali has published over 60 articles in scientific journals and is an inventor/coinventor of several US and European patents. He is the recipient of IPEC’s Henk de Jong Industrial Research Award. He has served as the USP council of experts for the General Chapters-Physical Analysis (2010-2020), and continues to serve as USP council of experts for the Excipient Test Methods committee (2020-2025). He is co-chair of the AAPS Lipid Focus Group.
For any technical questions, please contact Nicole Valle: nvalle@mjhevents.com